Anticoagulation for atrial fibrillation detected by device

+Practice

In print

Heartbeat

Anticoagulation for atrial fibrillation detected by device

8 May 2024

Chris Ellis

Wednesday 8 May 2024, 12:30 AM

[Image: Supplied]

Consultant cardiologist Chris Ellis looks at the management of short runs of atrial fibrillation detected by pacemaker

Key points, The management of device-detected short runs of atrial fibrillation is an increasing clinical dilemma, and clinical trials are trying to guide correct, Pract Green w Pale Yellow

Medicines and Therapies

References

1. Healey JS, Lopes RD, Granger CB, et al. Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med 2024;390(2):107–17.

2. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009;2(5):474–80.

3. Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of devicedetected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 2017;38(17):1339–44.

How to Treat

+How to treat

Polypharmacy

For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews

Wednesday 28 May 2025, 12:50 AM